Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism

Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism

Background. Patients with chronic hepatitis B virus (HBV) are often treated with nucleoside/nucleotide antiviral agents and metabolic bone toxicity is a possible concern.Objective. To determine the relationships between fibroblast growth factor 23 (FGF23), a phosphaturic hormone, bone mineral densit...

Full description

Bibliographic Details
Main Authors: Ramesh Saeedi, Ali Mojebi-Mogharar, Supna K. Sandhu, Joshua A. Dubland, Jo-Ann Ford, Masoud Yousefi, Morris Pudek, Daniel T. Holmes, Siegfried R. Erb, Wing C. Peter Kwan, David L Kendler, Eric M. Yoshida
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:Annals of Hepatology
Subjects:
HBV
Fibroblast growth factor 23
Hypophosphataemia
BMD
Vitamin D
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119303837

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119303837

Similar Items